Inhibiting the TGF-β signalling pathway as a means of cancer immunotherapy

Author: Kirkbride Kellye C   Blobe Gerard C  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.3, Iss.2, 2003-04, pp. : 251-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content